ATLANTA, April 13, 2022 (Newswire.com) – In a new deal announced today, TBI Therapy will implement AMP to deliver its neuroregenerative protocols to patients suffering from traumatic brain injury. The relationship will enable TBI Therapy to quickly scale its groundbreaking offerings to clinics and patients nationwide. The deployment of AMP in the neurological rehabilitation space further solidifies its stance as a specialty agnostic platform, one that empowers providers with the digital tools necessary to care for a range of patients.